Lanthanoidkomplexe von 1‐(2‐Propenyl)‐ und 1‐(3‐Butenyl)‐1,4,7,10‐tetraazacyclododecan‐4,7,10‐triessigsäure

η³‐1,4,7,10‐tetraazacyclododecane molybdenum tricarbonyl reacts with allyl bromide and 3‐butenyl bromide in dimethylformamide in the presence of K₂CO₃ yielding 1‐(2‐propenyl)‐1,4,7,10‐tetraazacyclododecane ( 1a ) and 1‐(3‐butenyl)‐1,4,7,10‐tetraazacyclododecane ( 1b ), which on their part react with bromoacetic acid tert‐butyl ester in CH₃CN to give 1‐(2‐propenyl)‐1,4,7,10‐tetraazacyclododecane‐4,7,10‐tris‐acetic acid tert‐butyl ester ( 2a ) and 1‐(3‐butenyl)‐1,4,7,10‐tetraazacyclododecane‐4,7,10‐tris‐acetic acid tert‐butyl ester ( 2b ), respectively. Compounds 2a and 2b are converted into the corresponding acids 1‐(2‐propenyl)‐1,4,7,10‐tetraazacyclododecane‐4,7,10‐tris‐acetic acid ( 4a ) (MPC) and 1‐(3‐butenyl)‐1,4,7,10‐tetraazacyclododecane‐4,7,10‐tris‐acetic acid ( 4b ) (MBC) via the trifluoroacetates 3a and 3b . Sm(NO₃)₃(H₂O)₆, LuCl₃(THF)₃, and TmCl₃(H₂O)₆ react with 4a and 4b forming the lanthanide complexes Sm(MPC) ( 5 ), Lu(MPC) ( 6 ), Tm(MPC) ( 7a ) and Tm(MBC) ( 7b ). The IR as well as the ¹H and ¹³C NMR spectra of the new compounds are reported and discussed.     

New routes to 1‐functionally substituted arylbenzotriazoles: 3‐Benzotriazol‐1‐yl‐pyridazine‐4‐ones, 5‐benzotriazol‐1‐yl‐pyridazine‐6‐ones and 5‐benzotriazol‐1‐yl‐pyridazine‐6‐imines

Condensation of 1‐arylhydrazono‐1‐benzotriazol‐1‐yl 2‐propanones ( 5a‐c ) with DMF DMA afforded 1‐aryl‐3‐benzotriazol‐1‐yl‐1,4‐dihydropyridazine‐4‐ones ( 8a‐c ). While condensation of 1‐functionally substituted methylbenzotriazoles 3b,c with 2‐arylhydrazono‐3‐oxoarylpropanal 13a,b give 3‐aroyl‐5‐(benzo‐triazolyl‐1‐yl)‐1,6‐dihydro‐1‐phenylpyridazine‐6‐ones and 6‐imines 14a‐d.     

1,3‐Dipolar cycloadditions of (4R*,5R*)‐1‐alkylidene‐4‐(benzoylamino)‐5‐phenyl‐3‐pyrazolidinon‐1‐azomethine imines

1,3‐Dipolar cycloadditions of azomethine imines 3a and 3b , available by acid‐catalyzed treatment of 3‐pyrazolidinone 1 with acetone ( 2a ) and butyraldehyde ( 2b ), respectively, were studied. Reactions of 3a with DMAD ( 4 ) afforded a mixture of products 9 and 10a , whilst treatment of 3b with DMAD ( 4 ) gave a mixture of compound 9 and epimeric cycloadducts 10 / 10′b . On the other hand, cycloadducts 13a,b‐16a,b were isolated as single diastereomers in 9–37% yields upon reactions of 3a,b with olefinic dipolarophiles 5–8 . The structures of cycloadducts 9, 10a, 10/10′b , and 13a,b‐16a,b were determined by ¹H nmr and NOESY spectroscopy. The structure of compound 13a was confirmed by X‐ray diffraction.     

Preparation of 2‐amino‐5‐methyl‐7H‐1,3,4‐thiadiazolo[3,2‐α]pyrimidin‐7‐ones

2‐Amino substituted 7H‐1,3,4‐thiadiazolo[3,2‐α]pyrimidin‐7‐ones 11a‐e were prepared by the reaction of 2‐bromo‐5‐amino‐1,3,4‐thiadiazole ( 1b ) and diketene ( 8 ), subsequent cyclocondensation ( 9b → 3b ) and displacement of the bromo substituents by the reaction with primary or secondary amines ( 3b → 11a‐e ). The hydrogen atom 6‐H in the heterobicycle 3b is replaced by a Cl or Br atom in the transformation of 3b → 14a,b. The 2‐bromo‐6‐chloro compound 14a reacts chemoselectively in the 2‐position with dimethylamine ( 14a → 15 ). The structure elucidations are based on one‐ and two‐dimensional NMR techniques including a heteronuclear NOE measurement.     

Synthesis of α‐alkylidene‐γ‐butyrolactones via Ring‐cleavage/recyclization of 2‐Amino‐4,5‐dihydro‐3‐furancarboxamides

The reactions of 2‐amino‐4,5‐dihydro‐3‐furancarboxarnides 1a,b with cyanomethylene compounds (such as alkyl cyanoacetates and malononitrile) gave the corresponding ring‐opened products 2a‐f. Compounds 2a‐d reacted with methanesulfonic acid to give the corresponding α‐alkylidene‐γ‐butyrolactones 3a‐d. On the other hand, treatment of 2e,f with methanesulfonic acid yielded 3‐pyridinecarbonitrile derivatives 4a,b.     

Biologically active 1‐arylpiperazines. Synthesis of N‐[3‐(4‐aryl‐1‐piperazinyl)propyl] derivatives of benzoxazinone and benzoxazolinone

The synthesis of new N‐[3‐(4‐aryl‐1‐piperazinyl)propyl] derivatives of 1H‐2,4‐benzoxazin‐3(4H)‐one ( 1a‐b ), 2H‐1,4‐benzoxazin‐3(4H)‐one ( 2a‐b, 3a‐b and 4b ), and benzoxazolin‐2‐one ( 5a‐b ), as biologically active agents, is described.     

Synthesis of 1‐methyl‐, 4‐nitro‐, 4‐amino‐and 4‐iodo‐1,2‐dihydro‐3H‐pyrazol‐3‐ones

4‐Aminopyrazole‐3‐ones 4b, e, f were prepared from pyrazole‐3‐ones 1b‐d in a four‐step reaction sequence. Reaction of the latter with methyl p‐toluenesulfonate gave 1‐methylpyrazol‐3‐ones 2b‐d . Compounds 2b‐d were treated with aqueous nitric acid to give 4‐nitropyrazol‐3‐ones 3b‐d. Reduction of compounds 3b‐d by catalytic hydrogenation with Pd‐C afforded the 4‐amino compounds 4b, e, f. Using similar reaction conditions, nitropyrazole‐3‐ones derivatives 2c, d were reduced into aminopyrazole‐3‐ones 5e, f. 4‐Iodopyrazole‐3‐ones 7a, 7c and 8 were prepared from the corresponding pyrazol‐3‐ones 2a, 2c and 6 and iodine monochloride or sodium azide and iodine monochloride.     

An efficient synthesis of 5‐aryl‐4,5‐dihydro‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐(4‐phenylthiazol‐2‐yl)pyrazoles

Some new target products 5‐aryl‐4,5‐dihydro‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐(4‐phenylthiazol‐2‐yl)pyrazoles 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j have been synthesized by reaction of 2‐bromo‐1‐phenylethanone and compounds 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h , 4i , 4j which were prepared from the combination of thiosemicarbazide and (E)‐3‐aryl‐1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐prop‐2‐en‐1‐ones 3a , 3b , 3c , 3d , 3e , 3f , 3g , 3h , 3i , 3j . All the structures were established by MS, IR, CHN, and ¹H NMR spectra data. Synthesis of structure diversity is applied. J. Heterocyclic Chem., (2011).     

Heterocyclic Systems Containing Bridged Nitrogen Atom: Synthesis and Antibacterial Activity of 3‐(2‐Phenylquinolin‐4‐yl)/3‐(1‐p‐Chlorophenyl‐5‐methyl‐1,2,3‐triazol‐4‐yl)‐s‐triazolo[3,4‐b]‐1,3,4‐thiadiazine Derivatives

The condensation of 4‐amino‐5‐mercapto‐3‐(2‐phenylquinolin‐4‐yl)/3‐(1‐p‐chlorophenyl‐5‐methyl‐1,2,3‐triazol‐4‐yl)‐1,2,4‐triazoles 1a‐b with chloroacetaldehyde 2a‐b , ω‐bromo‐ω‐(1H‐1,2,4‐triazol‐1‐yl)acetophenone 3a‐b , chloranil 4a‐b , 2‐bromocyclohexanone 5a‐b , 2,4′‐dibromoacetophenone 6a‐b and 2‐bromo‐6′‐methoxy‐2′‐acetonaphthone 7a‐b are described. The structures of the compounds synthesized were confirmed by elemental analyses, IR, 1H NMR and mass spectra. The antibacterial activities were also evaluated.     

Synthesis of 1‐Methyl‐6,10‐diphenylheptalene Derivatives

The reduction of heptalene diester 1 with diisobutylaluminium hydride (DIBAH) in THF gave a mixture of heptalene‐1,2‐dimethanol 2a and its double‐bond‐shift (DBS) isomer 2b (Scheme 3). Both products can be isolated by column chromatography on silica gel. The subsequent chlorination of 2a or 2b with PCl₅ in CH₂Cl₂ led to a mixture of 1,2‐bis(chloromethyl)heptalene 3a and its DBS isomer 3b . After a prolonged chromatographic separation, both products 3a and 3b were obtained in pure form. They crystallized smoothly from hexane/Et₂O 7 : 1 at low temperature, and their structures were determined by X‐ray crystal‐structure analysis (Figs. 1 and 2). The nucleophilic exchange of the Cl substituents of 3a or 3b by diphenylphosphino groups was easily achieved with excess of (diphenylphospino)lithium (=lithium diphenylphosphanide) in THF at 0° (Scheme 4). However, the purification of 4a / 4b was very difficult since these bis‐phosphines decomposed on column chromatography on silica gel and were converted mostly by oxidation by air to bis(phosphine oxides) 5a and 5b . Both 5a and 5b were also obtained in pure form by reaction of 3a or 3b with (diphenylphosphinyl)lithium (=lithium oxidodiphenylphospanide) in THF, followed by column chromatography on silica gel with Et₂O. Carboxaldehydes 7a and 7b were synthesized by a disproportionation reaction of the dimethanol mixture 2a / 2b with catalytic amounts of TsOH. The subsequent decarbonylation of both carboxaldehydes with tris(triphenylphosphine)rhodium(1+) chloride yielded heptalene 8 in a quantitative yield. The reaction of a thermal‐equilibrium mixture 3a / 3b with the borane adduct of (diphenylphosphino)lithium in THF at 0° gave 6a and 6b in yields of 5 and 15%, respectively (Scheme 4). However, heating 6a or 6b in the presence of 1,4‐diazabicyclo[2.2.2]octane (DABCO) in toluene, generated both bis‐phosphine 4a and its DBS isomer 4b which could not be separated. The attempt at a conversion of 3a or 3b into bis‐phosphines 4a or 4b by treatment with t‐BuLi and Ph₂PCl also failed completely. Thus, we returned to investigate the antipodes of the dimethanols 2a, 2b , and of 8 that can be separated on an HPLC Chiralcel‐OD column. The CD spectra of optically pure (M)‐ and (P)‐configurated heptalenes 2a, 2b , and 8 were measured (Figs. 4, 5, and 9).     

Reactions of 2‐amino‐4h‐1‐benzopyran‐4‐one with 4‐oxo‐4h‐1‐benzopyran‐3‐carbaldehydes

The title aldehyde 1 reacts smoothly with the enamine moiety of 2 ‐aminochromone 2 to produce hitherto unreported 3‐(2‐hydroxybenzoyl)‐5H‐1‐benzopyrano[2,3‐b]pyridin‐5‐one (azaxanthone) 5 . This reaction has been extended for the synthesis of bisazaxanthone 9.     

An Innovative Protocol for the Synthesis of 3‐(Pyridin‐2‐yl)‐5‐sec‐aminobiphenyl‐4‐carbonitriles and 9,10‐Dihydro‐3‐(pyridine‐2‐yl)‐1‐sec‐aminophenanthrene‐2‐carbonitriles

Herein, we present an innovative, novel, and highly convenient protocol for the synthesis of 3‐(pyridin‐2‐yl)‐5‐sec‐aminobiphenyl‐4‐carbonitriles ( 6a , 6b , 6c , 6d , 6e , 6f , 6g ) and 9,10‐dihydro‐3‐(pyridine‐2‐yl)‐1‐sec‐aminophenanthrene‐2‐carbonitriles ( 10a , 10b , 10c , 10d , 10e ), which have been delineated from the reaction of 4‐sec‐amino‐2‐oxo‐6‐aryl‐2H‐pyran‐3‐carbonitrile ( 4a , 4b , 4c , 4d , 4e , 4f , 4g ) and 4‐sec‐amino‐2‐oxo‐5,6‐dihydro‐2H‐benzo[h]chromene‐3‐carbonitriles ( 9a , 9b , 9c , 9d , 9e ) with 2‐acetylpyridine ( 5 ) through the ring transformation reaction by using KOH/DMF system at RT. The salient feature of this procedure is to provide a transition metal‐free route for the synthesis of asymmetrical 1,3‐teraryls like 3‐(pyridin‐2‐yl)‐5‐sec‐aminobiphenyl‐4‐carbonitriles ( 6a , 6b , 6c , 6d , 6e , 6f , 6g ) and 9,10‐dihydro‐3‐(pyridine‐2‐yl)‐1‐sec‐aminophenanthrene‐2‐carbonitriles ( 10a , 10b , 10c , 10d , 10e ). The novelty of the reaction lies in the creation of an aromatic ring from 2H‐pyran‐2‐ones and 2H‐benzo[h]chromene‐3‐carbonitriles via two‐carbon insertion from 2‐acetylpyridine ( 5 ) used as a source of carbanion.     

A Novel Synthesis of 1‐Aryl‐6‐bromo‐3‐(5‐ethylthio‐4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐pyrazolo[4,3‐b]quinolin‐9(4H)‐ones via Thermal Cyclization of 4‐Azidopyrazoles

2‐Aryl‐hydrazononitriles 3a , 3b , 3c were prepared by coupling 3‐ethylthio‐5‐cyanomethyl‐4‐phenyl‐1,2,4‐triazole ( 1 ) with diazonium salts 2a , 2b , 2c . Reacting 3a , 3b , 3c with both ethyl bromoacetate ( 4a ) and 4‐bromobenzyl bromide ( 4b ) in DMF, in the presence of K₂CO₃, at 80 °C for 3–4 h, gave the corresponding 4‐amino‐pyrazoles 6a , 6b , 6c , 6d , 6e , 6f . Diazotization of 6a , 6b , 6c , 6d , 6e , 6f , followed by reaction with NaN₃, leads to the formation of 4‐azidopyrazoles 8a , 8b , 8c , 8d , 8e , 8f , a new heterocyclic ring system. Interestingly, fusion of 4‐azidopyrazoles 8d , 8e , 8f at temperature higher than their melting points with 5 °C for 2 min did not give the expected fused pyrazolo[4,3‐c]isoxazoles 9 but furnished instead the novel pyrazolo[4,3‐b]quinolinones 10a , 10b , 10c , in high yields.     

Quinolone analogues 2. A facile synthesis of novel 3‐substituted 1‐alkyl‐4‐oxo‐1,4‐dihydropyridazino[3,4‐b]quinoxalines

The reaction of the 2‐(1‐alkylhydrazino)‐6‐chloroquinoxaline 4‐oxides 1a,b with diethyl acetone‐dicarboxylate or 1,3‐cyclohexanedione gave ethyl 1‐alkyl‐7‐chloro‐3‐ethoxycarbonylmethylene‐1,5‐dihydropyridazino[3,4‐b]quinoxaline‐3‐carboxylates 5a,b or 6‐alkyl‐10‐chloro‐1‐oxo‐1,2,3,4,6,12‐hexahydroquinoxalino[2,3‐c]cinnolines 7a,b , respectively. Oxidation of compounds 5a,b with nitrous acid afforded the ethyl 1‐alkyl‐7‐chloro‐3‐ethoxycarbonylmethylene‐4‐hydroxy‐1,4‐dihydropyridazino‐[3,4‐b]quinoxaline‐4‐carboxylates 9a,b , whose reaction with base provided the ethyl 2‐(1‐alkyl‐7‐chloro‐4‐oxo‐1,4‐dihydropyridazino[3,4‐b]quinoxalin‐3‐yl)acetates 6a,b , respectively. On the other hand, oxidation of compounds 7a,b with N‐bromosuccinimide/water furnished the 4‐(1‐alkyl‐7‐chloro‐4‐oxo‐1,4‐dihydropyridazino[3,4‐b]quinoxalin‐3‐yl)butyric acids 8a,b , respectively. The reaction of compound 8a with hydroxylamine gave 4‐(7‐chloro‐4‐hydroxyimino‐1‐methyl‐1,4‐dihydropyridazino[3,4‐b]quinoxalin‐3‐yl)‐butyric acid 12 .     

Structure analysis of some α‐(n‐methyl‐n‐formylaminomethyl)‐quinolines

The ¹H and ¹³C nmr spectra of the rotational isomers 3a and 3b of 6‐N‐methyl‐N‐formylaminomefhyl)‐thioquinanthrene were completely assigned with a combination of 1D and 2D nmr techniques. The key‐parts of this methodology were long‐range proton‐carbon correlations and NOE experiments with N‐methyl‐N‐formylaminomethyl substituent. The X‐ray study of 4‐methyl‐2‐N‐methyl‐N‐formylaminomethyl)quinoline 4a as well as ¹H and ¹³C nmr spectra show that N‐methyl‐N‐formylaminomethyl substituent in 4a and 4b has a different steric arrangement than the same substituent in 3a and 3b .     

Synthesis and bioactivity of 6‐bromo‐2‐(substituted)‐3‐(1‐phenyl‐ethyl)‐ 3,4‐dihydro‐1H‐ isophosphinoline 2‐chalcogenides

Synthesis of 6‐bromo‐2‐(substituted)‐3‐(1‐phenyl‐ethyl)‐3,4‐dihydro‐1H‐isophosphinoline 2‐chalco‐genides derivatives (6) were synthesized from 2‐[(1‐phenylethylamino)methyl]‐4‐bromophenol ( 1 ) by reaction with aryl/alkyl phosphoro dichloridates ( 2 ) in the presence of triethylamine at 55°C to 60°C to obtained the title compounds ( 6a‐g ). The title compounds ( 6h‐j ), were prepared via intermediate route. Few other title compounds ( 8a‐c ) were accomplished through a two step synthetic route involving 1 with dichlorophenyl phosphine ( 2a ) and dichloroethyl phosphine ( 2a,b ) in the presence of triethylamine in dry toluene under N₂ atmosphere to form the corresponding trivalent phosphorus intermediate (7) . In the second step they were further converted to the corresponding chalcogenides 8a‐c by reaction with hydrogen peroxide, sulfur and selenium respectively. They exhibited significant antibacterial, fungal and insecticidal activity.     

The formation of 3‐ferrocenylpyrazole‐4‐carboxylates and alkylhydrazine insertion products from α‐ferrocenylmethylidene‐β‐oxocarboxylates

The reactions of α‐ferrocenylmethylidene‐β‐oxocarboxylates ( 1 , 2 , 3a , and 3b ) with N‐methyl‐ and N‐(2‐hydroxyethyl)hydrazines ( 5a , 5b ) afford ethyl 1‐alkyl‐5‐aryl(methyl)‐3‐ferrocenylpyrazole‐4‐carboxylates ( 6a , 6b , 6c , 6d , 6e ) (～50%) and N‐alkylhydrazine insertion products, viz., ethyl (N′‐acyl‐N′‐alkylhydrazino)‐3‐ferrocenylpropanoates ( 7a , 7b , 7c , 7d , 7e ) (～20%) and 1‐acyl‐2‐(N′‐alkyl‐N′‐ethoxycarbonylhydrazino)‐2‐ferrocenylethanes ( 8a , 8b , 8c , 8d , 8e ) (～10%). The structures of the compounds obtained were established based on the spectroscopic data and X‐ray diffraction analysis (for pyrazoles 6a and 6b ). J. Heterocyclic Chem., (2011).     

Bifunktionalisierte 1 H‐Phosphiren‐ und g1‐1‐Phosphaallen‐Wolframkomplexe

Bifunctionalized 1 H‐Phosphirene and g¹‐1‐Phosphaallene Tungsten Complexes The tungsten(0) complex [{(Me₃Si)₂HCPC(Ph)=N}W(CO)₅] 1 reacts upon heating with acetylene derivatives 2 a–d in toluene to form benzonitrile and the complexes [{(Me₃Si)₂HCPC(R)=COEt} · W(CO)₅] 5 a–d ( 5 a : R = SiMe₃; 5 b : R = SiPh₃; 5 c : R = SnMe₃; 5 d : R = SnPh₃) and [{(Me₃Si)₂HCP=C=C(OEt)R} · W(CO)₅] 6 a, b ( 6 a : R = SnMe₃; 6 b : R = SnPh₃), which have been isolated by chromatography; complexes 5 c and 6 a have been characterized as mixtures. Spectroscopic and mass spectrometric data are discussed. The crystal structure of the compound 5 a was determined by X‐ray single crystal structure analysis ( 5 a : space group P2₁/n, Z = 4, a = 977.6(2) pm, b = 1814.6(4) pm, c = 1628.0(4) pm, β = 93.95(2)°).     

Reactions of 1‐(3‐aryl‐3‐oxopropenyl)azulenes and 1‐cinnamoylazulenes with malononitrile: Synthesis of 1‐(2‐aryl‐4‐pyridyl)azulenes and 1‐(4‐aryl‐2‐pyridyl)azulenes

The reactions of 1‐formyl‐3‐methoxycarbonylazulene ( 1 ) with acetophenones 3a‐e gave 1‐(3‐aryl‐3‐oxopropenyl)‐3‐methoxycarbonylazulenes 4a‐e which reacted with malononitrile in the presence of sodium methoxide to afford 1‐(2‐aryl‐4‐pyridyl)‐3‐methoxycarbonylazulenes 9a‐d , except for 4′‐nitro‐substituted compounds. Heating of the compounds 9a‐d in 100% phosphoric acid yielded 1‐(2‐aryl‐4‐pyridyl)azulenes 10a‐d . In a similar manner, 1‐(4‐aryl‐2‐pyridyl)azulenes 12a‐1 and 1‐[4‐(2‐furyl)‐ and 4‐(2‐thienyl)‐2‐pyridyl)]azulenes 14a,b were obtained.     

Quinolone Analogues 15: Synthesis and Antimalarial Activity of 4‐Phenyl‐1‐(1‐triazolylmethyl‐4‐quinolon‐3‐ylcarbonyl)semicarbazide and Related Compounds

The 1‐hydrazinocarbonylmethyl‐4‐quinolone‐3‐carboxylate ( 10 ) was converted into the 1‐(4‐amino‐1,2,4‐triazol‐3‐ylmethyl)‐4‐quinolone‐3‐carboxylic acid ( 13 ), whose reaction with arylcarbaldehydes gave the 1‐(4‐arylmethyleneamino‐1,2,4‐triazol‐3‐ylmethyl)‐4‐quinolone‐3‐carboxylic acids ( 5a , 5b , 5c , 5d , 5e , 5f , 5g ). Compound 10 was also transformed into the 1‐(4‐amino‐1,2,4‐triazol‐3‐ylmethyl)‐4‐quinolone‐3‐carbohydrazide ( 15 ), whose reaction with phenyl isocyanate or phenyl isothiocyanate afforded the 4‐phenyl‐1‐(1‐triazolylmethyl‐4‐quinolon‐3‐ylcarbonyl)semicarbazide ( 6a ) or 4‐phenyl‐1‐(1‐triazolylmethyl‐4‐quinolon‐3‐ylcarbonyl)thiosemicarbazide ( 6b ), respectively. Compounds 6a , 6b showed the in vitro antimalarial activity to chloroquine‐resistant Plasmodium falciparum, wherein their IC₅₀ was 3.89 and 3.91 μM, respectively.